A recently described AML entity, “AML with pDC differentiation” [50], demonstrated frequent RUNX1 mutations and expression of lymphoid antigens, comparable to RUNX1mut BP-CML. The gene discussed is RUNX1; the disease is acute myeloid leukemia.